Medicilon Biotechnology Pharmaceutical Bioanalysis Service Platform

Biotechnology drugs are known as one of the most promising areas in drug research and development in the 21st century. In recent years, more and more drug development has focused on this, and its bioanalysis has therefore attracted more and more attention. The Pharmaceutical Bioanalysis Department of Medicilon Biotechnology can provide domestic and foreign customers with better quality, greater throughput and higher efficiency biological analysis services.

Medicilon’s drug bioanalysis service team is composed of nearly 20 experienced technicians. Compared with the past, the equipment not only meets multiple configurations in quantity, but also adds a lot of new instruments, such as immunogenicity analysis. The gold standard instrument-the US MSD electrochemiluminescence immunoassay analyzer, etc. The laboratory implements comprehensive information management, and has established a complete sample management chain and experimental data processing, tracking and storage chain with the help of the verified laboratory information management system (Watson LIMS 7.2), which can provide customers with global quality service.

At present, most of the advanced treatment methods for major diseases in the world are related to biotechnology drugs, including tumor immunotherapy, which has been receiving wide attention recently. Antibody drugs, genetically recombinant protein drugs, vaccines and other biotechnological drugs have achieved remarkable results in the treatment and prevention of diseases, which have attracted the attention of governments of all countries. Since the first monoclonal antibody drug entered the market in 1986, more and more pharmaceutical companies have carried out biotechnology drug research and development. Among them, bioanalysis is an important link in the early stage of research and development, which is used to evaluate and explain pharmacokinetics and toxicology. The scientific basis for research on kinetics, pharmacodynamics, immunogenicity and bioequivalence.

Accurate and reliable analysis methods and true and effective data analysis are an integral part of the laboratory quality system. The Pharmaceutical Bioanalysis Department of Medicilon Biotechnology provides professional technical services that fully comply with FDA/CFDA GLP standards to support the screening and development of protein drugs, antibody drugs, vaccines and biomarkers, as well as preclinical and clinical research.

Part of biotechnology drug bioanalysis equipment:

Services available for bioanalysis of biotechnology drugs

(Mainly applicable to antibodies, ADCs, vaccines, proteins, etc.):

Macromolecule bioanalysis method development and methodological confirmation

Develop, transfer, optimize and validate immunoassay methods for the determination of drug concentration in biological matrices;

Develop optimized and have a variety of monoclonal antibodies (Adalimumab, Bevacizumab, Trastuzumab, Pertuzumab, etc.) and validated immunoassay methods for antibody-conjugated drugs

Protein, antibody, peptide and drug analysis and detection

Bioequivalence test

Pharmacokinetics, toxicity and immunogenicity tests

Radiolabeling (C14, H3, I125) and tissue distribution and pharmacokinetic research

Biomarker analysis and detection

Bone markers

Inflammation markers

Tumor markers

Metabolic disease markers

Cardiovascular disease markers

Vaccine analysis and testing

Multiple serotype antibodies

Monovalent and multivalent vaccines

Immunogenicity testing

Screening test
Deterministic test

Titer determination

Contact Us:

Email : marketing@medicilon.com

Tel : +44 1223 981 792（Europe）

+82 (0)70-8269-5849（South Korea）

08044216898（Japan）

+86 021 58591500（China )

Website: https://www.medicilon.com

What is Bioanalysis

In Vitro Enzyme Activity Assay

Kinases play extensive and important roles in signal transduction and co-ordination of complex functions. Currently, about 300 kinase inhibitors have been approved for marketing, among which receptor tyrosine kinase (RTK) inhibitors are the main ones. Medicilon provides high-quality kinase profile screening and has one-stop kinase research services from assay development, high-throughput screening to selectivity analysis. In addition, Medicilon provides many other enzyme activity screens. Wide Variety Provides 200+ in vitro enzymatic detection methods; 100+ kinases, including CTK, RTK, AGC, CMGC and other kinase families as well as important common mutations Project Flexibility Various types of plates for screening, such as 96 and 384; Multiple flexible kinase profiles, including TK kinase family, CDK kinase family, etc., to meet different customer customization needs. Various Methods Fluorescence detection; Chemiluminescence detection; Absorbance detection LanthaScr...

阅读全文

Custom Synthesis

Medicilon has synthesized over 10,000 individual compounds from gram to kilogram quantities, and many compounds are synthesized with more than ten synthetic steps. The overall synthesis success rate is over 95%. High quality products from mg to kg scale Reagents, intermediates, building blocks, and scaffolds Preparation of API or reference standards Development of synthetic routes for impurities and metabolites On-site analytical support Product delivered with COA Medicilon offers integrated drug discovery services -- Chemistry, Biology & Preclinical Services

阅读全文

Fluorescence Probes Synthesis

Medicilon's fluorescent probes and labeling platforms can provide fluorescent probe design and synthesis services for scientific institutions, drug R&D companies, and other customers. Design and synthesis steps Fluorescent probes are tools used to detect, measure and analyze biomolecules, cells and tissues. They achieve these purposes by emitting and receiving fluorescent signals. Medicilon can complete the design and synthesis of fluorescent probes for biomolecules. Selection of target molecules and determination of target. Selection of fluorescent dyes. Design of molecular structure. Synthesize probe molecules. Testing the properties of probe molecules. Custom synthesis Medicilon's fluorescent probes and labeling platforms can provide fluorescent probe design and synthesis services for scientific institutions, drug R&D companies, and other customers. After years of development, Medicilon's fluorescent probes and labeling platforms have accumulated rich experience...

阅读全文

Shanghai Medicilon Inc.

搜索此博客